Reuters: IPOX® Research Associate Lukas Muehlbauer Comments on Quantinuum’s Upsized U.S. IPO

Reuters reported that Honeywell’s Quantinuum is seeking a valuation of up to $14.3 billion in an upsized U.S. IPO, reflecting strong investor interest in quantum computing. The company is now aiming to raise up to $1.46 billion by offering 26.5 million shares priced between $53 and $55 apiece, above its earlier target of up to $1.05 billion.

IPOX® Research Associate Lukas Muehlbauer was quoted in the article, providing analysis on investor demand, valuation expectations and the timing of Quantinuum’s listing. He noted that the upsized offering points to strong institutional demand, while also highlighting the execution expectations embedded in the company’s valuation.

Reuters also cited Muehlbauer’s view that Quantinuum stands apart from many quantum companies that went public via SPACs, given its Honeywell lineage, operating history, substantial R&D investment and approximately 700 employees.

“The upsize suggests institutional demand is strong and that investors view Quantinuum as a scarce strategic asset. But at this valuation, the stock needs to price in years of successful execution before the revenue can catch up.”

“It is sensible for the company to take advantage of a receptive IPO window while investor enthusiasm for quantum remains high.”

“Quantinuum is differentiated from many quantum companies that went public via SPACs through the operating history from its Honeywell lineage, substantial ⁠R&D investment, and around 700 employees, which differentiates it from earlier-stage peers.”

Read the full article by Arasu Kannagi Basil on Reuters: Honeywell's Quantinuum eyes $14.3 billion valuation in upsized US IPO